Black Diamond Therapeutics, Inc
BDTX
Last
$1.83
Day
+1.1%
1y
-58.1%
5y
-77.5%
52w
-63.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
1.90
EMA 50
1.96
EMA 200
2.26
20d high
-11.3%
5y high
-79.2%
5y range
8th
Positions held
Your positionsBDTX isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.96
Stop
$1.69
Stop distance
7.7%
Target vs last
+7.1%
Fundamentals
| Market cap | $103.72M | Enterprise value | $10.46M | Trailing P/E | — | Forward P/E | -1.81 |
| PEG | — | Price / book | 1.08 | Beta | 3.33 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -37.2% | ROA | -19.1% | Debt / equity | 0.18 |
| Current ratio | 7.28 | Free cash flow | -$23.58M | Analyst recommendation | strong_buy | Mean target | $10.00 |
| 52w high | $4.94 | 52w low | $1.60 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$9.9M | -$9.0M | -$15.1M | -$8.5M | -$10.6M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$12.1M | -$11.3M | -$10.3M | -$11.0M | -$13.4M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $70.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | 28.4% | — | — | — | — |
| Net income | $22.4M | -$69.7M | -$82.4M | -$91.2M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | $19.9M | -$78.8M | -$86.5M | -$92.8M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-04 · Black Diamond (BDTX) Up 9.4% Since Last Earnings Report: Can It Continue?
2026-09-02 · Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
2026-08-05 · Black Diamond: Q2 Earnings Snapshot
2026-08-05 · Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Price (daily)
Full chart · RSI · MACD · patternsBDTX · daily-7.2% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin